Agno Pharma acquires Actylis Eugene, expanding US API manufacturing footprint
The Eugene facility, with more than 20 years of history, houses a 16,000-square-foot R&D lab and a newly constructed 30,000-square-foot manufacturing facility
The Eugene facility, with more than 20 years of history, houses a 16,000-square-foot R&D lab and a newly constructed 30,000-square-foot manufacturing facility
Eltrombopag tablets will be produced at the group’s formulation manufacturing facility at SEZ, Ahmedabad
The agreement responds directly to President Trump’s demands that drugmakers cut costs for US patients
The acquisition marks a major step in PAI’s strategy to expand domestic pharmaceutical manufacturing
Appointment supports AstraZeneca’s $50 billion US investment and ambition to reach $80 billion in Total Revenue by 2030
Tiger Shroff fronts ‘Fit Raho, Hit Raho’ campaign
Syrma Johari is a globally recognised medical device engineering and manufacturing organisation
Cupid is strengthening its footprint in the GCC region, focusing on supply responsiveness and market proximity
The new single-use commercial facility will be among India’s largest, featuring advanced technologies to produce high-quality biologics and specialty pharmaceuticals
The additional production will raise the installed capacity by 400 million and available capacity by 240 million at the facility
Subscribe To Our Newsletter & Stay Updated